Immuneering CorporationIMRXNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank50
Studio
Year-over-Year Change

Free cash flow yield

Latest
-15.71%
↑ 37% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-24.74%
Historical baseline
PeriodValueYoY Change
2025-15.71%+81.2%
2024-83.51%-253.7%
2023-23.61%+32.6%
2022-35.04%-382.4%
2021-7.26%-17.6%
2020-6.17%-228.8%
2019-1.88%-